Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06654245 · ClinicalTrials.gov registry record · NA
Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT06654245: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.
NCT06654245 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06654245, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This clinical trial evaluates whether a shared response plan (SHAREDCare) improves follow-up care for lung cancer survivors. As the number of cancer survivors increases, there is a new need for high-quality chronic illness care. High-quality chronic illness care can be difficult to deliver and involves working with the patient to be certain they have what they need to be actively involved with their care to meet their needs. SHAREDCare allows the patient to work with a navigator to review identified distress and social needs. The patient and navigator discuss the needs and develop a shared response plan to address the needs in ways that consider the patient's current behaviors, beliefs, and motivation. The plan also establishes specific patient goals, anticipates barriers, and establishes how the navigator will follow-up on the needs and adjust care and assistance when needed. Using a shared response plan may improve follow-up care for lung cancer survivors.
Primary Outcome
Will be assessed with semi-structured interviews. These methods will be guided by Grounded Theory, a process using inductive coding to develop theory from data (e.g., themes relating to components, timing, or delivery of the intervention).
Interventions
- OTHER Survey using a questionnaire.
- OTHER Electronic health record review
- OTHER Referral
- BEHAVIORAL Telephone based interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2026-01-12 |
| Phase | NA |
Why NCT06654245 stopped before completion
NCT06654245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which Survey using a questionnaire. is the first listed.
NCT06654245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06654245 about?
NCT06654245 is a clinical study titled "Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors". This clinical trial evaluates whether a shared response plan (SHAREDCare) improves follow-up care for lung cancer survivors. As the number of cancer survivors increases, there is a new need for high-quality chronic illness care. High-quality chronic illness care can be difficult to deliver and invol...
What is the current status of trial NCT06654245?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2025-06-11. Estimated completion is 2026-01-12.
What interventions are being tested in trial NCT06654245?
The interventions under investigation include: Survey using a questionnaire. (OTHER), Electronic health record review (OTHER), Referral (OTHER), Telephone based interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT06654245?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06654245's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI